selected scholarly activity
-
chapters
-
conferences
- Molecular Classification of Endometrial Cancers Using an Integrative DNA Sequencing Panel.. Journal of Surgical Oncology. S144-S145. 2024
- Adjuvant Radiation for Endometrioid Adenocarcinoma Stage II (AREAS2): A Canadian Cohort. International Journal of Radiation Oncology Biology Physics. E356-E357. 2019
- Interobserver Agreement for Mismatch Repair Protein Immunohistochemistry in Endometrial and Nonserous, Nonmucinous Ovarian Carcinomas. American Journal of Surgical Pathology. 591-600. 2019
- Interobserver Agreement for Mismatch Repair Protein Immunohistochemistry in Endometrial and Ovarian Carcinomas. Laboratory Investigation. 450-450. 2018
- The Pathologic and Treatment Factors Associated With Recurrence in Stage IA Serous Adenocarcinoma of the Uterus. International Journal of Radiation Oncology Biology Physics. E315-E315. 2016
- UNDIFFERENTIATED ENDOMETRIAL CANCER, A DIFFERENT ENTITY WITH AN AGGRESSIVE BEHAVIOR. International Journal of Gynecological Cancer. 69-69. 2015
- Ovarian cancer distribution of histology, stage, and screening performance. Journal of Clinical Oncology. 2013
- Screening for Lynch syndrome in unselected women with endometrial cancer. Journal of Clinical Oncology. 2013
- Prognostic Significance of Primary Tumour Factors in Stage III High Grade Endometrial Cancer. Modern Pathology. 280A-280A. 2012
- Prognostic Significance of Primary Tumour Factors in Stage III High Grade Endometrial Cancer. Laboratory Investigation. 280A-280A. 2012
- Outcomes of Adjuvant Intracavitary Brachytherapy Alone in Surgically Staged I/II, Grade 3 Endometrial Adenocarcinoma: The Cross Cancer Institute Experience from 1995 to 2006. International Journal of Radiation Oncology Biology Physics. S366-S366. 2009
-
journal articles
- Timing of Palliative Care, End-of-Life Quality Indicators, and Health Resource Utilization.. JAMA network open. 7:e2440977. 2024
- Information needs of Lynch syndrome and BRCA 1/2 mutation carriers considering risk-reducing gynecological surgery: a qualitative study of the decision-making process. Hereditary Cancer in Clinical Practice. 22:5. 2024
- Impact of molecular genotyping on the diagnosis and treatment of human chorionic gonadotropin-producing tumors. Journal of Gynecology Obstetrics and Human Reproduction. 53:102704-102704. 2024
- Intraoperative predictors of appendiceal abnormalities in patients with mucinous ovarian neoplasms. International Journal of Gynecology and Obstetrics. 164:249-254. 2024
- Palliative care utilization across health sectors for patients with gynecologic malignancies in Ontario, Canada from 2006 to 2018. Gynecologic Oncology. 175:169-175. 2023
- A Double-blinded, Randomized Trial Comparing Surgeon-Administered Transversus Abdominis Plane Block With Placebo After Midline Laparotomy in Gynecologic Oncology Surgery. Obstetrical and Gynecological Survey. 78:404-405. 2023
- Canadian Guideline on the Management of a Positive Human Papillomavirus Test and Guidance for Specific Populations. Current Oncology. 30:5652-5679. 2023
- A double-blinded, randomized trial comparing surgeon-administered transversus abdominis plane block with placebo after midline laparotomy in gynecologic oncology surgery. American Journal of Obstetrics and Gynecology. 228:553.e1-553.e8. 2023
- Inguinofemoral sentinel lymph node biopsy by scar injection in vulvar cancer: an assessment of feasibility and long-term outcomes. International Journal of Gynecological Cancer. 32:1512-1518. 2022
- Brief family history questionnaire to screen for Lynch syndrome in women with newly diagnosed non-serous, non-mucinous ovarian cancers. International Journal of Gynecological Cancer. 32:891-898. 2022
- The five-factor modified frailty index predicts adverse postoperative and chemotherapy outcomes in gynecologic oncology. Gynecologic Oncology. 166:154-161. 2022
- Estrogen receptor-positive adenocarcinoma of the cervix presenting during pregnancy: Two case reports and review of the literature. Gynecologic Oncology Reports. 39:100916-100916. 2022
- Maximizing cancer prevention through genetic navigation for Lynch syndrome detection in women with newly diagnosed endometrial and nonserous/nonmucinous epithelial ovarian cancer. Cancer. 127:3082-3091. 2021
- A pneumococcal pneumonia and influenza vaccination quality improvement program for women receiving chemotherapy for gynecologic cancers at a major tertiary cancer Centre. Gynecologic Oncology. 161:236-243. 2021
- Understanding the clinical implication of mismatch repair deficiency in endometrioid endometrial cancer through a prospective study. Gynecologic Oncology. 161:221-227. 2021
- Thirty‐day outcomes after gynecologic oncology surgery: A single‐center experience of enhanced recovery after surgery pathways. Acta Obstetricia et Gynecologica Scandinavica. 100:353-361. 2021
- Directive clinique no 408 : Prise en charge des maladies gestationnelles trophoblastiques. Journal of Obstetrics and Gynaecology Canada. 43:106-123.e1. 2021
- Guideline No. 408: Management of Gestational Trophoblastic Diseases. Journal of Obstetrics and Gynaecology Canada. 43:91-105.e1. 2021
- Tumor site discordance in mismatch repair deficiency in synchronous endometrial and ovarian cancers. International Journal of Gynecological Cancer. 30:1951-1958. 2020
- Performance characteristics of screening strategies to identify Lynch syndrome in women with ovarian cancer. Cancer. 126:4886-4894. 2020
- Bullous vesicant-type reaction to docetaxel along the venous tract: A case report. Gynecologic Oncology Reports. 34:100640-100640. 2020
- Guideline No. 403: Initial Investigation and Management of Adnexal Masses. Journal of Obstetrics and Gynaecology Canada. 42:1021-1029.e3. 2020
- No 370 - Prise en charge du carcinome malpighiende la vulve. Journal of Obstetrics and Gynaecology Canada. 41:102-115. 2019
- No. 370-Management of Squamous Cell Cancer of the Vulva. Journal of Obstetrics and Gynaecology Canada. 41:89-101. 2019
- Outcomes of Adjuvant Therapy for Stage IA Serous Endometrial Cancer. Cureus. 10:e3387. 2018
- Effectiveness of the Risk of Malignancy Index and the Risk of Ovarian Malignancy Algorithm in a Cohort of Women With Ovarian Cancer. International Journal of Gynecological Cancer. 25:809-814. 2015
- UNDIFFERENTIATED ENDOMETRIAL CANCER, A DIFFERENT ENTITY WITH AN AGGRESSIVE BEHAVIOR. International Journal of Gynecological Cancer. 25:69-69. 2015
- Performance characteristics of a brief Family History Questionnaire to screen for Lynch syndrome in women with newly diagnosed endometrial cancer. Gynecologic Oncology. 136:311-316. 2015
- Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing. Cancer. 120:3932-3939. 2014
- Systemic therapy in squamous cell carcinoma of the vulva: Current status and future directions. Gynecologic Oncology. 132:780-789. 2014
- Surgery for early stage cervical cancer: How radical should it be?. Gynecologic Oncology. 131:222-230. 2013
- International Gynecologic Cancer Society (IGCS 2012). Gynecologic Oncology. 128:12-14. 2013
- A Review of Surgical Options to Preserve Fertility in the Treatment of Early Cervical Cancer. Current Women's Health Reviews. 8:219-230. 2012
- Advancing fertility-sparing treatments in cervical cancer: Where is the limit?. Gynecologic Oncology. 126:317-318. 2012
- Combined methotrexate–dactinomycin: An effective therapy for low-risk gestational trophoblastic neoplasia. Gynecologic Oncology. 124:553-557. 2012
- Sentinel lymph node mapping in cervical cancer: the future?. BJOG: An International Journal of Obstetrics and Gynaecology. 119:129-133. 2012
- Follow‐up after chemoradiation for cervical cancer: Why?. Cancer. 117:3875-3878. 2011
- Fertility-sparing surgery in cervical cancer. US Obstetrics and Gynecology. 6:51-54. 2011
- Assessment of outcomes in surgically staged I/II endometrial adenocarcinoma patients treated with postoperative vaginal vault radiotherapy only.. International Journal of Gynecological Cancer. 20:1356-1362. 2010
- Conservative surgery for early stage cervical cancer: Who should we offer it to?. Gynecologic Oncology. 119:173-174. 2010